Physician profile
Robert D Grigg
NPI 1780698522
$5,418.17
in general payments reported to CMS, 2019-2025
19 companies · $1,614 in 2025
The $1,614 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,676 · 2020: $204 · 2021: $422 · 2022: $354 · 2023: $669 · 2024: $479 · 2025: $1,614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,968 · Travel and Lodging: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,967.97 |
| Travel and Lodging | $794.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,015.66 | 2019-2025 | Acuvue |
| Coopervision INC. | $1,334.04 | 2023-2025 | Myday Contact Lens, Clariti Contact Lens, Onefit Contact Lens |
| Bausch & Lomb Americas INC. | $485.52 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Novartis Pharmaceuticals Corporation | $291.41 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $215.03 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $213.85 | 2019-2025 | Total30, Precision 1 |
| Optos, INC. | $200.87 | 2019-2021 | |
| Abbvie INC. | $191.50 | 2022-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $92.44 | 2019 | |
| Kala Pharmaceuticals, INC. | $67.34 | 2021-2022 | |
| Shire North American Group INC | $65.42 | 2019 | |
| Allergan, INC. | $63.01 | 2020-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $60.55 | 2020 | |
| Abb Con-Cise Optical Group LLC | $28.44 | 2019 | |
| Mallinckrodt Hospital Products INC. | $23.75 | 2025 | Acthar |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $22.95 | 2023 | Tyrvaya |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Plexus Optix, INC. | $15.80 | 2021 | |
| Sun Pharmaceutical Industries INC. | $11.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Grigg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.